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ENDOSCOPIC SPOT
Endoscopic  resection  combined  with radiofrequency  ablation
for early  adenocarcinoma  in Barrett’s  esophagus
Mucosectomia  e  radiofrequência  na  terapêutica  de  adenocarcinoma
superﬁcial  em  esófago  de  Barrett
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rBarrett’s  esophagus  (BE)  is  a  premalignant  condition  that
results  from  the  replacement  of  the  normal  squamous  lin-
ing  of  the  esophagus  by  a  columnar  epithelium  containing
intestinal  metaplasia  (IM)  on  biopsy.
A  53-year-old  man  was  followed  at  our  institution  for
long-segment  BE  (Prague  classiﬁcation  C1  M4)  since  2007.
His  past  medical  history  was  unremarkable.  There  were  no
visible  nodules  or  ulcerations  within  the  BE  at  endoscopy  in
2007  and  2008.  Biopsies,  performed  according  to  the  Seattle
protocol,  were  negative  for  dysplasia.
The  patient  returned  in  2011  for  surveillance  endoscopy.
At  this  exam  a  ﬂat,  slightly  elevated,  lesion  (Paris  clas-
siﬁcation  0-IIa)  with  8  mm  of  diameter  was  noted  near
the  gastroesophageal  junction  (Fig.  1A).  Targeted  biop-
sies  were  compatible  with  intramucosal  adenocarcinoma.
Biopsy  specimens  of  the  remainder  BE  were  negative  for
dysplasia.Endoscopic  mucosal  resection  (EMR)  was  performed
with  the  patient  under  deep  sedation  with  propo-
fol.  We  used  the  Duette  Multiband  Mucosectomy  KitTM
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 modiﬁed  variceal  band  ligator  that  allows  passage
f  a  hexagonal  1.5  cm  ×  2.5  cm  snare  made  of  braided  wire
longside  the  releasing  wires  for  the  bands.  The  area  to  be
esected  was  previously  delineated  with  coagulation  mark-
ngs  (Fig.  1B).  The  lesion  was  ﬁrst  suctioned  into  the  ligating
arrel,  and  the  rubber  band  was  deployed  creating  a  pseu-
opolyp.  Resection  was  carried  out,  in  two  fragments,  with
he  ESG-100  electrosurgical  unit  (Olympus  Europe,  Ham-
urg,  Germany),  using  pure  coagulation  current  (Fig.  1C--F).
here  were  no  early  or  delayed  complications.  Specimens
ere  pinned  on  cork  and  ﬁxed  in  formalin.  Pathologic
xamination  revealed  a  moderately  differentiated  adeno-
arcinoma  limited  to  the  lamina  propria  (Fig.  2A--C).  Lateral
argins  were  not  evaluable  given  the  piecemeal  technique.
At  6-weeks  follow-up  endoscopy  there  were  no  signs  of
esidual  lesion  (Fig.  3A).  Biopsies  of  the  resection  scar  and
arrett’s  segment  showed  no  dysplasia.  Due  to  high  risk
f  metachronous  lesions  ablation  of  the  remaining  BE  was
cheduled.  Given  the  narrow  tongue-like  BE  morphology
e  selected  the  focal  ablation  catheter  to  minimize
otential  stricture  formation.  At  12-weeks  post  EMR
adiofrequency  ablation  (RFA)  was  carried  out  using  the
alo90 catheter  (BÂRRX  Medical  Inc.,  Sunnyvale,  CA,  USA)
logia Published by Elsevier España, S.L. All rights reserved.
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Figure  1  Endoscopic  images  of  early  cancer  in  BE  treated  by  EMR.  (A)  0-IIa  lesion  at  the  1  o’clock  position;  (B)  coagulation  markers
with tip  of  snare  for  orientation;  (C--E)  the  marked  area  was  suctioned  into  the  cap  and  a  rubber  band  was  released.  Resection  was
performed in  two  fragments;  (F)  EMR  wound;  no  markers  can  be  identiﬁed  indicating  an  endoscopically  complete  resection.
Figure  2  Pathological  examination.  (A--C)  Microscopic  view  of  the  specimen  showing  a  moderately  differentiated  adenocarcinoma
conﬁned to  the  lamina  propria;  there  is  no  inﬁltration  into  the  muscu
Figure  3  Follow-up  endoscopies  and  RFA.  (A)  EMR  scar  with-
out signs  of  residual/recurrent  lesion;  (B--C)  RFA  with  the  Halo90
catheter;  (D)  esophagus  with  normal-appearing  neosquamous
epithelium.
ﬁ
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flaris  mucosa  (red  line)  or  lymphovascular  invasion  (red  arrow).
tted  on  the  tip  of  a  standard  endoscope  (Fig.  3B--C).  Bar-
ett’s  epithelium  was  positioned  at  the  12  o’clock  position
n  the  endoscopic  video  image.  Areas  were  ablated  twice  by
sing  the  ‘‘double-double’’  15  J/cm2 regimen  (2  consecutive
blations  with  15  J/cm2 each,  with  cleaning  of  the  ablated
rea  after  the  ﬁrst  pass).  The  patient  was  kept  on  esomepra-
ole  (40  mg  BID  for  2  months  and  40  mg/day  thereafter)
nd  follow-up  at  2,  6,  9  and  12  months  after  RFA  showed
 esophagus  covered  with  normal-appearing  neosquamous
pithelium  (Fig.  3D).  Biopsies  were  negative  for  IM  and
ysplasia.
In  recent  years,  endoscopic  therapy  of  early  BE  neo-
lasia  has  become  a  safe  and  effective  alternative  to
sophagectomy.1,2 Only  patients  with  high-grade  intraep-
thelial  neoplasia  or  well  and  moderately  differentiated
ntramucosal  carcinoma  without  lymphatic  involvement
re  eligible  for  curative  endoscopic  treatment.3,4 Lesions
howing  invasion  of  the  submucosa  are  associated  with  a
igniﬁcant  risk  of  lymph  node  metastases  and  therefore
atients  should  be  treated  surgically.5 Due  to  the  risk  of
ynchronous  and  metachronous  lesions  in  the  remaining  BE,
omplete  ablation  of  the  metaplastic  epithelium  should
ollow  a  successful  resection  of  dysplastic  lesions.
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